COMMUNIQUÉS West-GlobeNewswire
-
Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference
12/11/2026 -
Maple Report: More than half of Canadian patients and families report being left without adequate updates while waiting for care
12/11/2026 -
Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
12/11/2026 -
MediWound Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026 -
Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance
12/11/2026 -
Satellos Reports Third Quarter 2026 Financial Results and Highlights Company Progress
12/11/2026 -
Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture
12/11/2026 -
American Shared Hospital Services Reports Third Quarter and Nine-Month 2026 Financial Results
12/11/2026 -
Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
12/11/2026 -
10 Barrel Brewing, Widmer Brothers and Hop Valley Named Official Craft Beer Partners of the Portland Trail Blazers
12/11/2026 -
Verano Celebrates Grand Opening of MÜV Daytona Beach on Friday, November 13th, Expanding the Company’s Retail Footprint to 88 Florida Dispensaries and 165 Nationwide
12/11/2026 -
Cardiff Oncology Reports Third Quarter 2026 Results and Provides Business Update
12/11/2026 -
Parabilis Medicines Reports Third Quarter 2026 Financial Results and Provides Business Updates
12/11/2026 -
Hyperion DeFi Reports Q3 2026 Financial Results with Third Consecutive Quarterly Record Net Income, Achieving Breakeven Guidance on Core Operations and Cash Flows
12/11/2026 -
Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform
12/11/2026 -
AAVantgarde to present progress toward the first treatment for Usher syndrome type 1B at EYENOVATE and FLORetina 2026
12/11/2026 -
Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewer Treatment-Related Adverse Events and No Viral Rebounds Versus PAXLOVID®
12/11/2026 -
OKYO Pharma to Participate in 2026 Jefferies Global Healthcare Conference in London
12/11/2026 -
VETmAb Biosciences Appoints Katja Buhrer as Chief Operating Officer
12/11/2026
Pages